Company Name Curreio, Inc.
HQ Location Room 357, South Clinical Research Laboratory, Tokyo University, 7-3-1, Hongo, Bunkyo-ku, Tokyo, Japan, 113-8485
Representative CEO Motoki Nakai
Establishment August 2019
Capital Approximately 380 million yen (including capital reserve)
Business Contents Drug discovery and R & D business based on structural analysis using Cryo-EM
Legal Advisor Anderson Mōri & Tomotsune
Shareholders Beyond Next Ventures, Ono Venture Investment, Asahi Kasei Pharma, GEMSEKI, Etc.